Le Manach et al. present a study demonstrating the experimental applicability of changes in pulse pressure variation (dPPV) for the prediction of changes in cardiac output (dCO). The study is accompanied by a panegyric editorial answering the rhetorical question whether we need to monitor CO during surgery with a resounding NO! We now have dPPV! 1,2 There is, however, a number of considerations to be made before this opinionist view is acceptedor rejected.
Should We Offer the Surgeon a Break?
To the Editor: Le Manach et al. present a study demonstrating the experimental applicability of changes in pulse pressure variation (dPPV) for the prediction of changes in cardiac output (dCO). The study is accompanied by a panegyric editorial answering the rhetorical question whether we need to monitor CO during surgery with a resounding NO! We now have dPPV! 1, 2 There is, however, a number of considerations to be made before this opinionist view is acceptedor rejected.
1. None of the studies adduced in support of fluid optimization through CO maximization deal with oxygen delivery: one was a review, one was historical, and remaining four were centered on volume optimization. 2. It is questionable whether transesophageal measurements reliably measures changes in CO of less than 1 l/min, 3,4 this may eliminate 152 of 402 patients from the analysis. 3. The evaluation of PPV is strictly restricted to the anaesthetized, muscle-relaxed patient being positive pressure ventilated. It is based on the Frank-Starling cardiac function curve to the exclusion of considerations of venous return. The caveats to its use, so far published, run into 10. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] The PPV methodology assesses a leftsided response to a right-sided excitation, and the signal has to pass four valves, four chambers, and two vascular systems, and you will never know whether the arrival of the signal causes constructive or destructive interference with the cyclic inflation of the lungs. It is not clear whether the authors checked all of these caveats, or how many patients were excluded from the study for these reasons. It is not clear why optimization should be restricted to the peroperative period. 4. The experimental procedure needs a baseline, an intervention, and a new assessment. Certainly, many modalities exist to assess the response to volume infusion. In the current study, thermodilution, pulse contour analysis, esophageal Doppler, and transesophageal echocardiography are specifically mentioned. Although effective, each requires the addition of technology and invasiveness beyond standard monitoring, which is not universally available or necessary. Omitted from both this study and the accompanying editorial is reference to using our standard monitors in the assessment of this response.
Through 4 demonstrated that changes in ETCO 2 after passive leg raising had a sensitivity of 90.5% and specificity of 93.7% to predict fluid responsiveness using a methodology similar to many of the pulse pressure variation and stroke volume variation models. We frequently use the arterial-ETCO 2 gradient as part of our assessment of CO and the trend of this gradient to assess the impact of therapeutic interventions, the most common of which being intravascular volume expansion.
We thank Le Manach et al. for their work and suggest that it teaches very important lessons in cardiovascular physiology and volume management. Although the authors demonstrated the use of pulse pressure variation for assessing hemodynamic responses to fluid administration, we suggest that our standard monitoring already provides substantial information about our patients' hemodynamic status. More advanced, invasive, and expensive monitoring should continue to be applied on a case-by-case basis.
